Company intelligence / Profile preview

Amide Pharmaceutical

Little Falls, New Jersey, United Statesamidetech.com ↗

Ownership: Private
Employees: ~200
Development stage: Commercial

Overview

Amide Pharmaceutical was a US manufacturer of over 80 solid dosage form (tablet and capsule) generic drug products for a range of indications. At the time of its 2005 acquisition, it marketed 67 products, had 12 ANDAs pending with the FDA, and a development pipeline of roughly 30 products. The company focused on prescription generic drugs and supported both its own and private label distribution. The site operated under US cGMP, with substantial US market penetration and a capacity of over 1.5 billion tablets/year (expandable to 6–8 billion).

Modalities: Small molecule
Industry: Biotech

Drug pipeline

2 assets

Amigesic

1 more asset in the full pipeline.

Partnerships

Mylan

Beyond the preview

Go deeper on Amide Pharmaceutical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Amide Pharmaceutical.